Postoperative pain remains one of the most significant challenges in perioperative medicine, affecting patient recovery, satisfaction, and clinical outcomes. Inadequately managed pain following surgery is associated with prolonged hospital stays, increased risk of chronic pain syndromes, higher rates of complications such as pneumonia and deep vein thrombosis, and impaired respiratory function [1,2]. In India, the burden of undertreated postoperative pain is particularly substantial, given the high surgical caseloads in tertiary care centres and the heterogeneous nature of analgesic practices across institutions. The World Health Organization estimates that more than 300 million surgeries are performed globally each year, with a significant proportion of patients reporting moderate-to-severe postoperative pain despite available pharmacological interventions [3]. Conventional analgesic approaches have traditionally relied on systemic opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and paracetamol as part of postoperative pain management protocols. While opioids remain effective for moderate-to-severe pain, their use is associated with dose-dependent adverse effects, including nausea, vomiting, sedation, respiratory depression, and the risk of long-term dependency [4,5]. These limitations have prompted the anaesthesia community to explore opioid-sparing strategies as part of enhanced recovery after surgery (ERAS) protocols. Multimodal analgesia, which integrates multiple pharmacological and non-pharmacological methods targeting different pain pathways, has gained widespread acceptance as a more balanced approach to perioperative pain management [6]. Peripheral nerve blocks (PNBs), facilitated by the widespread adoption of ultrasound guidance, represent a transformative advancement in regional anaesthesia. By delivering local anaesthetic agents directly in proximity to specific nerve trunks or plexuses, PNBs can provide highly targeted, profound analgesia that covers the surgical site without the systemic effects associated with centrally acting opioids [7,8]. Techniques such as the brachial plexus block, femoral nerve block, sciatic nerve block, transversus abdominis plane (TAP) block, and intercostal nerve blocks have demonstrated clinical utility across a range of surgical specialties including orthopaedics, general surgery, thoracic surgery, and breast surgery [9,10]. The integration of ultrasound guidance has significantly improved the accuracy, safety, and consistency of these procedures, reducing the risk of inadvertent vascular puncture, pneumothorax, and local anaesthetic systemic toxicity [11]. Despite growing evidence supporting PNBs in the international literature, their routine adoption in Indian tertiary care hospitals remains inconsistent, with limited published comparative data from the Indian clinical context. Studies examining the efficacy of PNBs in South Asian patient populations, where comorbidity profiles, surgical volumes, and healthcare resource availability differ significantly from Western centres, are particularly scarce [12]. Furthermore, there is a need for prospective data that simultaneously evaluates pain scores, analgesic requirements, haemodynamic stability, and complication profiles in a single comparative study. The present study was therefore designed to provide such evidence, comparing the effectiveness of peripheral nerve blocks against conventional systemic analgesia for perioperative pain management in adult surgical patients at a tertiary care hospital in Hyderabad, India, during the period of June 2022 to January 2023. 2. OBJECTIVE The primary objective of this study was to evaluate and compare the effectiveness of ultrasound-guided peripheral nerve blocks versus conventional systemic analgesia in the management of perioperative pain in adult patients undergoing elective surgery at a tertiary care centre in Hyderabad, India. Effectiveness was assessed using the Visual Analogue Scale (VAS) pain scores at multiple postoperative time points (2, 6, 12, and 24 hours), time to first rescue analgesia, and total analgesic consumption over a 24-hour postoperative period [13]. The secondary objectives were to compare haemodynamic stability including heart rate, systolic blood pressure (SBP), diastolic blood pressure (DBP), and oxygen saturation (SpO2) between the two groups, and to document and compare the incidence of postoperative adverse events such as nausea, vomiting, sedation, respiratory depression, and local anaesthetic toxicity signs. Additionally, patient satisfaction with pain management was assessed as a tertiary outcome, providing a patient-centred dimension to the overall evaluation.

Study Design and Setting This was a prospective, open-label, randomised comparative clinical study conducted in the Department of Anaesthesiology at a tertiary care hospital in Hyderabad, Telangana, India, over a period of eight months from June 2022 to January 2023. Ethical approval was obtained from the Institutional Ethics Committee (IEC) prior to commencement of the study (Reference No. IEC/2022/ANE/047). All participants provided written informed consent in accordance with the Declaration of Helsinki [14]. Patients were randomly allocated into one of two groups using a computer-generated randomisation sequence with sealed opaque envelopes to minimise allocation bias. Group A received ultrasound-guided peripheral nerve blocks as the primary analgesic intervention, while Group B received conventional systemic analgesia as per standard departmental protocols. Blinding of patients and clinical assessors to group allocation was not feasible given the nature of the interventions; however, all pain assessments were conducted by a dedicated research nurse blinded to the assigned group. Inclusion and Exclusion Criteria Inclusion Criteria: (1) Adult patients aged 18–65 years scheduled for elective surgery under general or spinal anaesthesia; (2) ASA Physical Status Grade I or II; (3) surgeries involving the upper or lower limbs, abdominal wall, or breast and chest wall amenable to peripheral nerve block technique; (4) willingness and ability to provide written informed consent; (5) baseline VAS score assessable and documented preoperatively. Exclusion Criteria: (1) Known allergy or hypersensitivity to local anaesthetic agents including lignocaine or bupivacaine; (2) pre-existing coagulopathy or patients receiving therapeutic anticoagulation; (3) infection at the proposed site of nerve block; (4) ASA Grade III or above; (5) pre-existing peripheral neuropathy or neurological deficits affecting the surgical limb; (6) chronic pain conditions requiring daily opioid therapy; (7) pregnancy; (8) patient refusal or inability to provide consent; (9) emergency surgical cases; (10) patients with a body mass index (BMI) exceeding 40 kg/m2. Data Collection Procedure and Statistical Analysis All patients underwent standard preoperative assessment including medical history, clinical examination, and routine laboratory investigations. Preoperative analgesic requirements and baseline VAS scores were recorded. In Group A, ultrasound-guided peripheral nerve blocks were performed by experienced anaesthesiologists using a high-frequency linear probe (GE LOGIQ e portable ultrasound system). The specific block technique was selected based on the anatomical distribution of the surgical site: brachial plexus block (interscalene or axillary approach) for upper limb surgeries, femoral nerve block combined with sciatic nerve block for lower limb orthopaedic procedures, TAP block for abdominal surgeries, and paravertebral block for breast and chest wall procedures. Bupivacaine 0.25% was the principal local anaesthetic used, with volumes ranging from 15 to 30 mL per block depending on the anatomical site and patient weight. Group B patients received intraoperative intravenous fentanyl (1–2 mcg/kg) and postoperatively received IV paracetamol 1 g every 8 hours combined with intramuscular diclofenac 75 mg as needed for pain. Rescue analgesia in both groups consisted of IV morphine 0.05 mg/kg titrated to a VAS score of ≤3 [15]. VAS pain scores were assessed at rest at pre-specified time points: preoperatively and at 2, 6, 12, and 24 hours postoperatively. Heart rate, SBP, DBP, and SpO2 were monitored using continuous pulse oximetry and non-invasive blood pressure monitoring at each assessment point. Total morphine consumption and the number of rescue analgesia doses were documented over 24 hours. Adverse events were recorded throughout the postoperative observation period. Statistical Data Analysis: All data were entered and analysed using IBM SPSS Statistics Version 26.0 (IBM Corp., Armonk, NY, USA). Continuous variables were expressed as mean ± standard deviation (SD); categorical variables as frequency and percentage. Normality of distribution was assessed using the Shapiro-Wilk test. Normally distributed continuous variables between the two groups were compared using the independent samples Student's t-test; non-normally distributed variables were compared using the Mann-Whitney U test. Categorical variables were analysed using the Chi-squared (χ2) test or Fisher's exact test as appropriate. A two-tailed p-value of less than 0.05 was considered statistically significant. Kaplan-Meier survival analysis was used to estimate time to first rescue analgesia, with log-rank test for between-group comparison.

A total of 50 patients were enrolled in this study, with 25 patients in Group A (PNB) and 25 patients in Group B (conventional analgesia). The two groups were well-matched in terms of demographic characteristics and baseline clinical parameters (Table 1). The mean age was 38.6±11.2 years in Group A and 40.1±12.4 years in Group B (p=0.627). The distribution of ASA physical status grades and the duration of surgical procedures were comparable between the groups (p>0.05), confirming the adequacy of randomisation. Table 1: Demographic and Baseline Characteristics of Study Participants (n=50) Parameter Group A PNB (n=25) Group B Conventional (n=25) Total (n=50) p-value Age (years) – Mean±SD 38.6±11.2 40.1±12.4 39.4±11.8 0.627 Male – n (%) 14 (56%) 13 (52%) 27 (54%) 0.771 Female – n (%) 11 (44%) 12 (48%) 23 (46%) 0.771 Weight (kg) – Mean±SD 64.8±9.6 66.2±10.1 65.5±9.9 0.592 ASA Grade I – n (%) 15 (60%) 14 (56%) 29 (58%) 0.776 ASA Grade II – n (%) 10 (40%) 11 (44%) 21 (42%) 0.776 Duration of Surgery (min) – Mean±SD 98.4±24.6 102.1±26.8 100.3±25.7 0.594 Analysis of postoperative pain scores revealed a statistically significant and clinically meaningful difference between the two groups at all time points beyond the preoperative baseline. As shown in Table 2 and Figure 1, Group A consistently demonstrated lower mean VAS scores across all postoperative assessments. At the 2-hour post-operative mark, Group A had a mean VAS of 2.1±0.7 compared to 5.8±1.1 in Group B (p<0.001), reflecting a clinically significant reduction in early postoperative pain. This difference was sustained at 6 hours (2.4±0.8 vs 5.2±1.0; p<0.001), 12 hours (2.8±0.9 vs 4.7±1.2; p<0.001), and 24 hours (2.6±0.7 vs 3.9±1.0; p<0.001). The distribution of surgical procedure types among participants is depicted in Figure 2. Table 2: Comparison of Mean VAS Pain Scores at Various Time Points Between Groups Time Point Group A PNB Mean±SD Group B Conventional Mean±SD Mean Difference p-value Pre-operative Baseline 3.2±0.8 3.4±0.9 0.2 0.394 2 hours post-op 2.1±0.7 5.8±1.1 3.7 <0.001 6 hours post-op 2.4±0.8 5.2±1.0 2.8 <0.001 12 hours post-op 2.8±0.9 4.7±1.2 1.9 <0.001 24 hours post-op 2.6±0.7 3.9±1.0 1.3 <0.001 Analgesic consumption data further substantiated the superiority of peripheral nerve block analgesia (Table 3). The mean total morphine consumption over 24 hours was significantly lower in Group A (6.8±2.4 mg) compared to Group B (18.2±4.6 mg; p<0.001), representing approximately a 63% reduction in opioid requirements. The time to first rescue analgesia was substantially prolonged in Group A (8.4±2.1 hours) relative to Group B (2.6±0.9 hours; p<0.001). Notably, 8 patients (32%) in Group A required no rescue analgesia throughout the entire 24-hour observation period, compared to none in Group B (p=0.003). Patient satisfaction was significantly higher in Group A, with 88% of patients scoring above 4 out of 5 on the satisfaction scale versus 56% in Group B (p=0.011). Haemodynamic parameters remained more stable in Group A at the 2-hour postoperative assessment, with significantly lower heart rate, SBP, and DBP compared to Group B (Table 4). The overall incidence of adverse events was significantly lower in Group A (24%) versus Group B (72%; p=0.001), with nausea/vomiting and sedation being the most common adverse events in Group B (Table 5). Table 3: Analgesic Consumption and Time to First Rescue Analgesia Parameter Group A PNB Group B Conventional p-value Time to 1st rescue analgesia (hrs) – Mean±SD 8.4±2.1 2.6±0.9 <0.001 Total morphine consumption 24 hrs (mg) – Mean±SD 6.8±2.4 18.2±4.6 <0.001 No. of rescue analgesia doses – Mean±SD 1.2±0.6 3.8±1.1 <0.001 Patients requiring no rescue analgesia – n (%) 8 (32%) 0 (0%) 0.003 Patients satisfied (>4/5 satisfaction scale) – n (%) 22 (88%) 14 (56%) 0.011 Table 4: Haemodynamic Parameters at Key Postoperative Time Points Parameter Time Point Group A PNB Mean±SD Group B Conventional Mean±SD p-value HR (beats/min) Pre-op 76.2±9.4 77.8±10.1 0.537 HR (beats/min) Post-op 2 hrs 74.6±8.8 86.4±10.6 <0.001 SBP (mmHg) Pre-op 122.4±12.6 124.8±13.2 0.468 SBP (mmHg) Post-op 2 hrs 118.8±11.4 136.2±14.8 <0.001 DBP (mmHg) Pre-op 78.6±8.2 79.4±8.8 0.721 DBP (mmHg) Post-op 2 hrs 76.4±7.8 88.6±10.4 <0.001 SpO2 (%) Post-op 2 hrs 98.4±0.8 97.6±1.2 0.006 Table 5: Incidence of Adverse Events in Study Groups Adverse Effect Group A PNB n (%) Group B Conventional n (%) p-value Nausea/Vomiting 3 (12%) 9 (36%) 0.042 Sedation (Ramsay >3) 1 (4%) 6 (24%) 0.038 Respiratory Depression (SpO2 <94%) 0 (0%) 2 (8%) 0.148 Hypotension (SBP <90 mmHg) 1 (4%) 3 (12%) 0.296 Local Anaesthetic Toxicity Signs 1 (4%) 0 (0%) 0.313 Pruritus 2 (8%) 4 (16%) 0.384 Any Adverse Event 6 (24%) 18 (72%) 0.001

The present study provides robust comparative evidence that ultrasound-guided peripheral nerve blocks offer significant advantages over conventional systemic analgesia for perioperative pain management in adult surgical patients within a tertiary care setting. The most compelling finding was the statistically significant and sustained reduction in postoperative VAS pain scores in Group A at all measured time points, alongside markedly reduced opioid consumption and prolonged time to first rescue analgesia. These findings are consistent with and extend the evidence base from several landmark studies in regional anaesthesia. Ilfeld and Enneking demonstrated that continuous PNBs provided superior analgesia compared to intravenous opioid regimens for orthopaedic procedures, with patients in the nerve block group reporting significantly lower pain scores throughout the immediate postoperative period [7]. Similarly, Hadzic et al. reported that nerve block-based anaesthesia in ambulatory settings was associated with shorter recovery times, reduced analgesic requirements, and lower rates of nausea and vomiting compared to general anaesthesia with systemic opioids [9]. Our findings replicate these outcomes in an Indian tertiary care context, thereby strengthening the generalisability of this body of evidence across diverse clinical environments. The approximately 63% reduction in total 24-hour morphine consumption in Group A compared to Group B represents a clinically meaningful opioid-sparing effect, with important implications for postoperative recovery and patient safety. Opioid-associated adverse effects, particularly nausea, vomiting, sedation, respiratory depression, and delayed return of gut motility, are significant contributors to prolonged hospital stay and patient dissatisfaction following surgery [4,5]. In the present study, the incidence of nausea and vomiting was 12% in Group A versus 36% in Group B (p=0.042), and sedation occurred in 4% versus 24% of patients respectively (p=0.038), both differences consistent with the opioid-sparing effect of PNBs. The preservation of haemodynamic stability in Group A, evidenced by significantly lower post-operative heart rate and blood pressure compared to Group B, further reflects better pain control and reduced sympathoadrenal activation. Uncontrolled pain is a major driver of haemodynamic disturbance in the postoperative period; the superior analgesic profile of PNBs thus translates into measurable haemodynamic benefits that are particularly relevant for patients with cardiovascular comorbidities [10,11]. The higher patient satisfaction rates in Group A (88% vs 56%) also underscore the patient-centred value of incorporating nerve block techniques into perioperative analgesic protocols. From a mechanistic perspective, PNBs achieve superior analgesia by interrupting nociceptive transmission at the level of the peripheral nerve, thereby preventing the sensitisation of central pain pathways that underlies the development of persistent postoperative pain [6,8]. This is in contrast to systemic opioids, which modulate pain centrally without addressing the peripheral nociceptive input. The use of ultrasound guidance, as employed in the present study, further enhances the efficacy and safety of PNBs by enabling real-time visualisation of the needle, target nerve, and surrounding structures, thereby reducing the risk of inadvertent intravascular injection and ensuring optimal local anaesthetic deposition [11]. One patient in Group A (4%) developed transient signs suggestive of mild local anaesthetic toxicity, which resolved spontaneously without requiring lipid emulsion therapy; this underscores the importance of careful patient monitoring during and after block performance, as well as adherence to safe maximum dose thresholds. Overall, the data from the present study strongly support the integration of peripheral nerve blocks as a cornerstone of multimodal perioperative pain management in Indian tertiary care hospitals, in keeping with contemporary ERAS guidelines and international best practice recommendations [13,15]. 6. LIMITATIONS OF THE STUDY This study has several limitations that should be considered when interpreting the findings. First, the relatively small sample size of 50 patients may limit the statistical power to detect smaller, clinically meaningful differences in secondary outcomes such as specific adverse event rates and may affect the generalisability of results. Second, the open-label design, although necessitated by the nature of the interventions, introduces the possibility of performance and detection bias; although pain assessments were conducted by a blinded research nurse, the patients and treating anaesthesiologists were not blinded to group allocation. Third, the study was conducted at a single tertiary care centre in Hyderabad, which may limit the applicability of findings to other healthcare settings, particularly smaller hospitals where ultrasound-guided nerve block expertise may be unavailable. Fourth, the follow-up period was restricted to 24 hours postoperatively; data on longer-term outcomes such as chronic postsurgical pain, return to functional activity, and overall quality of life were not captured. Fifth, the heterogeneous nature of surgical procedures included in the study, while enhancing the external validity of the findings, introduces a degree of variability in the types of nerve blocks performed and in the analgesic requirements expected for different operations. Future larger multicentre randomised controlled trials with longer follow-up and stratified surgical subgroup analyses are needed to address these limitations. 7. ACKNOWLEDGMENT The authors sincerely thank the Department of Anaesthesiology and the nursing staff of the postoperative care unit at the tertiary care hospital, Hyderabad, for their invaluable support in patient recruitment, data collection, and clinical monitoring throughout the study period. We are grateful to all study participants for their willingness to contribute to this research. The authors also acknowledge the statistical guidance provided by the Department of Community Medicine, and the Institutional Ethics Committee for their prompt and thorough review of the study protocol. No external funding was received for this study.

This prospective comparative clinical study conducted at a tertiary care hospital in Hyderabad, India between June 2022 and January 2023 provides compelling evidence for the superiority of ultrasound-guided peripheral nerve blocks over conventional systemic analgesia in the perioperative management of surgical pain. Patients in the PNB group consistently experienced significantly lower VAS pain scores at all postoperative time points, a markedly prolonged time to first rescue analgesia, substantially reduced total opioid consumption over 24 hours, and superior haemodynamic stability compared to patients receiving conventional analgesia. The proportion of patients achieving complete rescue analgesia-free postoperative periods was significantly higher in the PNB group, and patient satisfaction with pain management was substantially better. The overall adverse event burden, including opioid-related complications such as nausea, vomiting, and sedation, was significantly lower in the PNB group, reflecting the opioid-sparing benefit of regional analgesic techniques. These findings collectively support the incorporation of peripheral nerve blocks as a standard component of multimodal perioperative pain management protocols in Indian tertiary care hospitals, particularly for orthopaedic, abdominal, and breast surgical procedures amenable to targeted regional block techniques. Anaesthesia departments should invest in training programmes to build and sustain ultrasound-guided nerve block competencies, and institutional protocols should be updated to reflect the evidence base supporting PNBs as a first-line analgesic strategy within ERAS frameworks. Future large-scale multicentre randomised trials across diverse Indian surgical populations, including higher-risk patient groups, are warranted to further refine patient selection criteria, evaluate cost-effectiveness, and examine the impact of PNBs on longer-term outcomes such as chronic postsurgical pain, length of hospital stay, and health-related quality of life. The results of the present study add to the growing body of evidence that positions peripheral nerve blocks as a safe, effective, and patient-centred analgesic approach for perioperative care

1. McQuay H, Moore A. Postoperative pain: management and improvement. In: Macintyre PE, Schug SA, Scott DA, editors. Clinical Pain Management: Acute Pain. 2nd ed. London: Arnold; 2003. p. 252–70. 2. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97(2):534–40. 3. World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: WHO; 2018. 4. McHugh GA, Thoms GM. The management of pain following day-case surgery. Anaesthesia. 2002;57(3):270–5. 5. Wehling M. Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities. Eur J Clin Pharmacol. 2014;70(10):1159–72. 6. Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists. J Pain. 2016;17(2):131–57. 7. Ilfeld BM, Enneking FK. Continuous peripheral nerve blocks at home: a review. Anesth Analg. 2005;100(6):1822–33. 8. Bivins HG, Ford S, Bezmalinovic Z, Price HM, Williams JL. The effect of axillary nerve blockade on the perioperative analgesic requirements. Reg Anesth. 1988;13(2):75–8. 9. Hadzic A, Arliss J, Kerimoglu B, Karaca PE, Yufa M, Claudio RE, et al. A comparison of infraclavicular nerve block versus general anesthesia for hand and wrist day-case surgeries. Anesthesiology. 2004;101(1):127–32. 10. Klein SM, Evans H, Nielsen KC, Tucker MS, Warner DS, Steele SM. Peripheral nerve block techniques for ambulatory surgery. Anesth Analg. 2005;101(6):1663–76. 11. Sites BD, Brull R. Ultrasound guidance in peripheral regional anesthesia: philosophy, evidence-based medicine, and techniques. Curr Opin Anaesthesiol. 2006;19(6):630–9. 12. Panda NB, Bharti N, Prasad S. Minimal effective dose of ketamine for caudal analgesia in children undergoing day care surgery. Paediatr Anaesth. 2008;18(3):237–41. 13. Fearon KC, Ljungqvist O, Von Meyenfeldt M, Revhaug A, Dejong CH, Lassen K, et al. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr. 2005;24(3):466–77. 14. World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4. 15. Hebl JR, Dilger JA, Byer DE, Kopp SL, Stevens SR, Pagnano MW, et al. A pre-emptive multimodal pathway featuring peripheral nerve block improves perioperative outcomes after major orthopedic surgery. Reg Anesth Pain Med. 2008;33(6):510–7. 16. Khan JS, Mathew G, Cheng M, Ramsay T, Hutton B, McCartney CJ, et al. Continuous peripheral nerve blocks for the management of postoperative pain: a systematic review and meta-analysis. Pain. 2021;162(3):741–52. 17. Neal JM, Brull R, Horn JL, Liu SS, McCartney CJ, Perlas A, et al. The ASRA Evidence-Based Medicine Assessment of Ultrasound-Guided Regional Anesthesia. Reg Anesth Pain Med. 2010;35(2 Suppl):S1–9. 18. Auroy Y, Benhamou D, Bargues L, Ecoffey C, Falissard B, Mercier FJ, et al. Major complications of regional anesthesia in France: the SOS Regional Anesthesia Hotline Service. Anesthesiology. 2002;97(5):1274–80.